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Abstract 
Polyphenols are naturally occurring compounds that are 
found within numerous plant sources. They have a wide vari-
ety of structures and functions and have potential clinical 
uses in multiple disease states. Emerging studies involving 
polyphenols have demonstrated their antioxidative proper-
ties, as well as reduced risks of cardiovascular diseases and 
certain types of cancer. Due to these discoveries, there has 
been a marked increase in research related to the chemical 
properties of polyphenols and their potential uses in preven-
tion of common acquired and inherited disease states. This 
article focuses on the effects that some polyphenolic com-
pounds exert on immune function in regard to the induction 
and clinical manifestations of the allergic response and how 
supplementation with polyphenol-enriched apple extracts 
may alter the approach to treating atopic dermatitis and food 
allergies. Currently, due to the lack of large clinical trials de-
tailing efficacy and safety data for these compounds when 
used to alter immune system responses to allergens, there 
are no strong recommendations for their use as prevention 
or acute treatment strategies for allergies. 
Introduction 
Researchers have been searching for natural products that 
are able to influence immune responses in regard to allergic 
disorders. Dietary polyphenols have been identified in multi-
ple preclinical and a limited number of human trials as hav-
ing the potential to alter the body's sensitivity to allergens 
and treat the allergic symptoms.1,2 These compounds have 
been extensively researched in the past for many other con-
ditions due to their anti-inflammatory and antioxidant prop-
erties, but the true connection to allergic disorders is still 
unclear. Polyphenols have shown benefits in studies focusing 
on animal models by having activity at the sensitization stage 
and during re-exposure to an allergen. 
Most available therapies focus on treating allergy symptoms 
and not on the prevention or moderation of the allergic reac-
tion. Current clinical recommendations for the treatment of 
symptoms associated with allergies include oral and topical 
antihistamines, corticosteroids, anticholinergics and mast 
cell stabilizers, which all focus on reducing the severity of the 
immune response and are relatively effective at doing so.3,4 
However, these medications should not be used long-term or 
in excessive doses due to an increased risk in associated ad-
verse effects. For instance, long-term use of topical corticos-
teroids can cause side effects ranging from local skin atrophy 
to the development of Cushing's syndrome.s Also, although 
uncommon, overuse of antihistamines can result in adverse 
events as serious as QT prolongation and cardiac arrhyth-
mias due to the drugs' inverse agonist activity at the Hista-
mine 1 receptor (H1).6 It is clear that there is a need for a 
therapeutic option that can effectively treat symptoms, as 
well as decrease the overall frequency of outbreaks by 
changing sensitivity to an allergen. 
Allergic Immune Response 
The exact mechanism of an immune response, while varied 
and specific for a particular allergen, generally revolves 
around the synthesis and resulting activity of inflammatory 
mediators, such as cytokines and interleukins that are pro-
duced by activated T helper (TH) cells of the adaptive im-
mune system.7 These cells communicate with each other and 
with other cells of the immune system through the timed 
release of chemical mediators. These mediators' further acti-
vation of immune processes focuses on the isolation, destruc-
tion and removal of a "non-self' substance in order to avoid 
potentially adverse insults and to regulate normal internal 
homeostasis. TH cells involved in this process are broken 
down and classified into two subcategories based upon cyto-
kine production, through which subsequent immune cell 
types are activated and the specific protective outcome in-
duced. Ttt1 cells stimulate a nonspecific cellular immune re-
sponse through the secretion of interferon gamma (IFN-y) 
that activates innate immune system mediators including 
monocytes, tissue macrophages and natural killer (NK) cells. 
lFN-y can also stimulate cytotoxic T-lymphocytes (Tc cells), 
as well as activate inducible nitric oxide synthase (iNOS) to 
produce nitric oxide (NO) free radicals in order to directly 
target bacteria and protozoa. Ttt2 cells focus on stimulating 
the production of adaptive immune cells, B lymphocytes, ba-
sophils and eosinophils, in addition to up-regulating antigen-
specific antibodies, which regulate humoral immunity.7.a 
Other cell types that are activated by this response include 
lmmunoglobulin E (IgE), which stimulates mast cells to re-
lease histamine, serotonin and leukotrienes in order to cause 
bronchoconstriction. Optimal immune function relies on a 
dynamic balance between the two processes to effectively 
eradicate any foreign threat that is detected. Exaggerated 
allergic responses become problematic when there is an im-
balance between TH1 and TH2 immunity, causing an overpro-
duction ofTH2 pathway products. 
An allergic disorder develops when the immune system de-
tects a harmless allergen, considers it a threat and mounts 
local and systemic responses through Ttt2 cell activity.1 The 
immune response to the initial allergen exposure not only 
works to rid the body of the foreign contaminate through 
innate immune function, but will additionally sensitize the 
adaptive immune system to recognize the particular allergen 
more readily upon re-exposure.9 This is accomplished 
through the production of antigen-specific IgE by plasma 
cells matured from activated B lymphocytes in response to 
the cytokines produced by Ttt2 cells, most notably inter-
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leukin 4 (IL-4).9,10 Binding of these antigen-specific lgE mole-
cules to the reintroduced allergen will cause symptoms of 
acute phase, as well as late phase immune reactions, due to 
the degranulation of mast cells. Inflammatory mediators re-
leased from these mast cells (histamine, interleukins and 
prostaglandins) can enhance vascular leakage while 
chemoattractants recruit basophils and eosinophils, as well 
as leukocytes in later stages, to the area of allergic reaction. 
Other cytokines cause upregulation of adhesion molecules 
for these leukocytes on vascular endothelial surfaces, which 
is critical for the progression to late phase reactions and 
chronic inflammation in future allergic reactions.1.2.9.10 
In regard to specific types of allergic responses, food allergies 
can begin to develop during infancy after ingestion of an al-
lergy-provoking food, but throughout life environmental fac-
tors can trigger respiratory allergies or skin allergies such as 
atopic dermatitis. Allergic reactions can also occur in part 
due to a genetic predisposition, called atopic syndrome 
(atopy).11 This increased reactivity is characterized by the 
preferential production of IgE in response to allergens whose 
clinical manifestations may include atopic dermatitis, allergic 
contact urticaria, dyshidrotic eczema, allergic rhinitis, 
asthma, conjunctivitis, gastrointestinal allergies or any com-
bination of the above.11 An important diagnostic criteria of 
atopic syndrome is the production of allergen-specific IgE. 
Gene polymorphisms critical for the development of atopic 
syndrome are involved in the regulation of the TH1/TH2 ratio. 
Upon exposure to a specific allergen in a patient with atopy, 
the ratio skews toward a predominantly TH2 cell response 
and the corresponding cytokine production. An overactiva-
tion of TH2 lymphocytes against these presented antigens 
will cause a type I IgE-mediated allergy and hypersensitivity. 
More recently, alterations in genes for mast cell chymase 
(found only in dermal mast cells), and the a and~ chains for 
the IgE receptor (representing a "gain of function" allele) 
have also been implicated in the preferential production of 
Ttt2 cells and their respective cytokines.11 
Polyphenol Chemistry 
Polyphenols are naturally occurring and biologically active 
chemicals that are found in a variety of fruits (apples and 
grapes), plants (vegetables and legumes) and drinks (wine, 
cider, beer and tea) that are part of the human diet. They are 
considered nonnutrients because they are not required for 
normal body functions such as growth and development.12 
Polyphenolic compounds are byproducts of major metabolic 
pathways in plants and are extremely diverse in their chemi-
cal presentation. Currently, over 8,000 polyphenols have 
been identified, contributing significantly to the varied struc-
tures and bioactivity in plants and humans.13 The highest 
concentrations of polyphenols are found in the parts of the 
plant source that are highly exposed to light, especially the 
leaves. Lower concentrations of polyphenols are found in 
portions of the plant that are underground, such as the tu-
bers and roots. 
Polyphenols have been considered deleterious to health due 
to their ability to bind to and precipitate proteins and other 
macromolecules, altering protein and macronutrient diges-
tion and absorption from the gastrointestinal tract, as well as 
altering gut physiology (pH, colonic flora, biliary excretion, 
transit time, etc.).14 Results of more recent studies have indi-
cated that these interactions may also interfere with the 
bioavailability of polyphenols although the exact interaction 
remains undetermined. Renewal of interest in polyphenols, 
especially flavonoids, has been due to their proven antioxi-
dant effects as free radical scavengers, Vitamin C and E re-
generators and inhibitors of low density lipoprotein (LDL) 
oxidation. These properties have prompted research about 
other potential health benefits that these compounds may 
provide, including their potential use in altering immune re-
sponse to allergic processes.13 One of the most well-
renowned types of polyphenols, the flavonoids, have dis-
played some medicinal applications in disease states includ-
ing hypertension, allergies and hypercholesterolemia, and 
also as anti-inflammatory agents, anti-ulceratives, antibiotics 
and antidiarrheals.13 
The overall structure of polyphenols is defined by the pres-
ence of one or more hydroxyl groups attached to aromatic 
rings.i.12 Additional chemical and structural classifications of 
polyphenols divide this broad class of molecules into at least 
10 subclasses depending on numerous factors including 
structural complexity, the presence of conjugated sugar 
groups, as well as other heteroatom linkages such as carbox-
ylic acids, amines and phenols that alter the basic chemical 
structure.13 The most basic classifications of polyphenols can 
be made into the following four groups: flavonoids, phenolic 
acids, stilbenes and lignans. Flavonoids and phenolic acids 
are the most abundant classes of polyphenols found in the 
human diet and can be further categorized based upon the 
location of hydroxyl groups. Flavonoids, with subclasses of 
flavones, isoflavones, flavanones, flavanols, flavonols and 
flavan-3-ols, are naturally abundant and are the basic build-
ing blocks of more complex polyphenols such as tannins 
which are highly hydrolyzed compounds capable of forming 
insoluble deposits with proteins.13 
Polyphenols and Atopic Dermatitis 
The possible anti-allergic effects of polyphenols have 
sparked studies looking at the potential benefits that supple-
mentation could bring to patients suffering from skin aller-
gies such as atopic dermatitis. Within the Atopy Outpatient 
Clinic of Kojima Hospital located in Tokyo, Japan, researchers 
examined the impact of apple extract supplementation on 
patients with atopic dermatitis.15 Apple condensed tannins 
(ACT) were extracted from unripe apples and formulated 
into an oral dosage. Condensed tannins, also referred to as 
proanthocyanidin, are built from the flavan-3-ol class ofpoly-
phenols and have comparatively high molecular weights.12 
Previous studies in animal models had predicted that tannins 
are able to inhibit histamine release from mast cells and ba-
sophils, but this pilot study aimed to determine if ACTs are 
effective in human subjects as welJ.15 Twenty-four patients 
between the ages of 8 and 18 years suffering from atopic der-
matitis were selected for participation in the study, and then 
randomly divided into treatment or standard treatment con-
trol groups. Groups were determined to be comparable in 
regard to gender, age, peripheral eosinophil levels, and se-
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rum IgE levels. Initially, both groups of patients began a stan-
dardized treatment using bufexamac ointment, half doses of 
alclometasone dipropionate ointment and hydroxyzine hy-
drochloride tablets (strengths and doses of medications not 
specified), which would be continued throughout the study 
period. Two weeks into the study, the treatment group added 
the ACT supplement to the regimen, dosed at 10 mg/kg di-
vided into two daily doses. At the end of the ten-week study, 
the severity of the atopic dermatitis was assessed using a 
scoring system. The severity of each of the following was 
rated on a scale of zero to two: inflammation, cracking and 
hardening of the skin. Each location on the body, defined as 
trunk, arms, legs and face, counted as a separate score. Itch-
ing and sleep disturbances were also evaluated using a scale 
of zero to three. Total scores greater than 21 points were 
classified as severe. Starting and ending levels of serum IgE, 
peripheral eosinophils, glutamic oxaloacetic transaminase 
(GOT) and glutamic pyruvic transaminase (GPT) were also 
obtained from each patient. IgE and eosinophil counts were 
used to measure the change in the immune response with 
treatment; whereas, GOT and GPT values acted as nonspe-
cific indicators of inflammation and tissue damage that are 
often elevated in dermatitis cases. 
Patients receiving the ACT treatment showed a decrease in 
dermatitis scores overall (amount of decrease not specified), 
especially in the categories of itching and sleep distur-
bance.is Also in the treatment group, a statistically significant 
decrease was seen in peripheral eosinophil levels 
(525 versus 760/µL at baseline; p<0.01), but there was no 
significant difference in these levels within the control group 
(673 versus 784/µL at baseline). Neither group showed a 
significant difference in IgE, GOT and GPT levels. The study 
concluded that ACT supplementation may be effective at de-
creasing atopic dermatitis when used in combination with 
standard treatment with no significant side effects. This 
study was only performed to gather baseline data on the use 
of apple extract supplements in the treatment of atopic der-
matitis. In summary, results were positive regarding the im-
provement in allergic symptoms, but additional studies using 
a larger patient population are needed to assess symptom 
management and the possibility of an ACT effect on the sen-
sitization stage of allergic disorders. 
Polyphenols and Food Allergies 
The research regarding the anti-allergic effects of polyphenol 
research has extended beyond skin allergies to examine the 
potential impact on food allergies. Researchers in Switzer-
land studied the use of apple extracts for the reduction of 
food allergy symptoms in mice.16 The apple extracts chosen 
for the trial had been enriched with polyphenols, mainly fla-
vonols. To begin, all mice were sensitized to the allergen 
ovalbumin (OVA), the main protein found in egg, using 
weekly doses of 20 mg. As an adjuvant, 10 µg of Cholera toxin 
(CT) was also given to the mice to ensure sensitivity to the 
allergen would develop during the seven weeks under study. 
Previous studies have found CT to stimulate long-term im-
munological memory, particularly in the gut mucosa.17 At the 
same time, mice were divided into four groups.16 One group 
received the apple extract (1 % weight-in-weight) in their 
food pellets during the sensitization process, and another 
group started the apple extract in the final week of the sensi-
tization process which was used to detect secondary preven-
tion. The study used two controls; the positive control group 
was not treated with the apple extract, and the negative con-
trol group was only sensitized to CT and not OVA. At the end 
of the seven weeks, the mice were given a challenge to the 
newly sensitized allergen using 100 mg OVA. Allergic reac-
tions in the mice were observed for 30 minutes and scores 
were recorded based on the severity and frequency of symp-
toms including scratching, bristled fur, diarrhea, labored res-
piration and anaphylaxis. Blood, lymph node and intestine 
samples were then obtained from the animal subjects. 
Results of the study were generally positive in concern to the 
benefits of polyphenol-enriched apple extracts. As expected, 
the negative control group did not experience any symptoms 
upon challenge to the antigen. Mice who received the apple 
extract during the final week of sensitization to test the sec-
ondary prevention hypothesis had significantly lower obser-
vation scores for symptoms. However, the mice ingesting the 
apple extract throughout the entire sensitization period did 
not experience fewer symptoms compared to the positive 
control group, which may show that polyphenols cannot pre-
vent the development of an allergic response. Serum IgE lev-
els were not found to vary in any of the mice regardless of 
apple extract treatment, but lower levels of cytokines were 
released from lymph nodes in the treated population of mice. 
A protease from intestinal mast cells, known to be involved 
in allergic responses to food allergens, was found in lower 
concentrations only in the secondary treatment group, which 
suggests an inhibition of the effector cell. Researchers tested 
the hypothesis that polyphenols may bind to proteins and 
lead to a diminished immune response. In vitro experiments 
showed that macro-complexes formed between the apple 
extract and OVA, resulting in decreased antibody reactivity. 
Contrary to expectation, in mice receiving the apple extract 
in their food pellets throughout the entire sensitization proc-
ess, the apple extract provided no benefit as a primary pre-
vention mechanism. 
Conclusion 
Although common in dietary sources, polyphenols are often 
used as a supplement and are available as an extract that has 
been formulated into an oral dosage. A variety of natural 
polyphenol products are available over the counter, and 
pharmacists must be knowledgeable about the current op-
tions and safety information for proper patient counseling. 
Supplements on the store shelf may be labeled as tablets or 
capsules containing polyphenols in general or may specify a 
particular category of polyphenols such as flavonoids. Poly-
phenol-containing compounds are marketed mainly for their 
antioxidant properties. It is expected that extracts from fruits 
or plants act as the main ingredients in these products. Some 
of the most common polyphenol products purchased by pa-
tients include green tea, grape, berry or apple extracts. 
Because of the limited number of human trials that have 
been conducted, proper dosing of polyphenol supplements is 
still unknown. Bioavailability of oral preparations of these 
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compounds is relatively low and dependent on the size of the 
chemical structure, which varies greatly between the sub-
classes.12 Dosing becomes a balance of finding a high enough 
dose to cause the intended effect, such as decreasing allergic 
symptoms, but not causing adverse reactions due to exces-
sive intake. For instance, high concentrations of polyphenols 
have been found to cause decreased viability of liver cells, 
interruption of cell signaling cascades and auto-oxidation 
processes within cells.12 
Additional research is still necessary to fully determine 
bioavailability, optimal dosing, and overall safety of 
polyphenolic compounds in human subjects. The ability of 
polyphenol supplementation to alter the body's sensitivity to 
allergens and to treat allergic symptoms is still under investi-
gation. Although it seems certain these compounds exhibit 
chemical mechanisms that may justify their therapeutic use 
in allergic responses, adequate scientific trials in large pa-
tient populations are not yet available. As pharmacists, it is 
important to educate patients on the risks associated with 
taking excessive doses of polyphenol supplements. However, 
difficulties in designing dosing regimen strategies may arise 
due to limited research data on the levels necessary to 
achieve a clinically significant effect and also due to the large 
variety of polyphenolic compounds available for use. Despite 
the promising potential for the use of polyphenol-containing 
products in the moderation of allergic immune responses, 
polyphenol supplements should not be recommended as an 
effective option for allergy purposes until further research is 
conducted. 
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